Itraconazole corneofungimetry bioassay on Malassezia species

Summary

[1]  E. Guého,et al.  The genus Malassezia with description of four new species , 1996, Antonie van Leeuwenhoek.

[2]  E. Guého,et al.  The diversity ofMalassezia yeasts confirmed by rRNA sequence and nuclear DNA comparisons , 2004, Antonie van Leeuwenhoek.

[3]  G. Piérard,et al.  Euclidean and Fractal Computer-Assisted Corneofungimetry: A Comparison of 2% Ketoconazole and 1% Terbinafine Topical Formulations , 2002, Dermatology.

[4]  R. Summerbell,et al.  In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine , 2000, The British journal of dermatology.

[5]  P. Doncker,et al.  Reduction in the growth of non‐dermatophyte moulds by itraconazole: evaluation by corneofungimetry assay: Beeinträchtigung des Wachstums von Nicht‐Dermatophyten‐Schimmeln durch Itraconazol: Bewertung mittels korneofungimetrischer Methode , 1998, Mycoses.

[6]  G. Piérard,et al.  Experimental dermatophyte infection abated by povidone-iodine: assessment by computerized-assisted corneofungimetry. , 1998, International journal of molecular medicine.

[7]  G. Piérard,et al.  Povidone-iodine wash solutions in the prevention of superficial fungal infections; predictive evaluation using the corneofungimetry bioassay , 1997, European Journal of Clinical Pharmacology.

[8]  E. Guého,et al.  Identification of Malassezia species : A practical approach , 1996 .

[9]  C. Piérard‐franchimont,et al.  Fungal cultures on cyanoacrylate skin surface strippings as a dose-finding method for topical antifungals. A placebo-controlled study with 0.25% and 0.50% itraconazole cream. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[10]  G. Piérard,et al.  Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study. , 1995, Journal of the American Academy of Dermatology.

[11]  T. Nishikawa,et al.  Application of neutral red staining for evaluation of the viability of dermatophytes and Candida in human skin scales. , 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[12]  G. Piérard,et al.  Comparative study of the activity and lingering effect of topical antifungals. , 1993, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[13]  M. Richardson,et al.  Germination of Trichophyton mentagrophytes on human stratum corneum in vitro. , 1992, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[14]  G. Piérard,et al.  Bioavailability of fluconazole and ketoconazole in human stratum corneum and oral mucosa , 1991, Clinical and experimental dermatology.

[15]  G. Piérard,et al.  Growth of Candida albicans on the stratum corneum of diabetic and non‐diabetic patients , 1990, Mycoses.

[16]  G. Piérard,et al.  Culture of fungi on cyanoacrylate skin surface strippings‐a quantitative bioassay for evaluating antifungal drugs , 1989, Clinical and experimental dermatology.

[17]  J. Faergemann.  A new model for growth and filament production of Pityrosporum ovale (orbiculare) on human stratum corneum in vitro. , 1989, The Journal of investigative dermatology.

[18]  H. Maibach,et al.  Growth and filament production of Pityrosporum orbiculare and P. ovale on human stratum corneum in vitro. , 1983, Acta dermato-venereologica.

[19]  A. Knight.  Human models for in vivo and in vitro assessment of topical antifungal compounds , 1973, The British journal of dermatology.

[20]  A. Knight.  Culture of dermatophytes upon stratum corneum. , 1972, The Journal of investigative dermatology.